Furthermore, the product of FADS1 ω-6 desaturation, arachidonic acid (AA), has also been implicated in multiple human cancers, including AML where elevated plasma AA levels are associated with adverse risk (2, 11, 12). This evidence concerns the gene FADS1 and cancer.